Evidence map›Paper›PMID 27937044›Full record

ArticlePharmaceutical biology2017

3-Hydroxy-4,7-megastigmadien-9-one, isolated from Ulva pertusa, attenuates TLR9-mediated inflammatory response by down-regulating mitogen-activated protein kinase and NF-κB pathways.

Irshad Ali, Zahid Manzoor, Jung-Eun Koo, Jung-Eun Kim, Sang-Hee Byeon, Eun-Sook Yoo, Hee-Kyoung Kang, Jin-Won Hyun, Nam-Ho Lee, Young-Sang Koh

Open access · hybridAbstract read
In one paragraph

Article in Pharmaceutical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Marine drugs · 2025
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Inhibitory Effects of Cucurbitane-Type Triterpenoids fromMolecules (Basel, Switzerland) · 2021
    Article
  8. Bioactive Compounds fromPlants (Basel, Switzerland) · 2020
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Irshad Alia School of Medicine and Brain Korea 21 PLUS Program , Jeju National University , Jeju , South Korea.
Zahid Manzoora School of Medicine and Brain Korea 21 PLUS Program , Jeju National University , Jeju , South Korea.
Jung-Eun Kooa School of Medicine and Brain Korea 21 PLUS Program , Jeju National University , Jeju , South Korea.
Jung-Eun Kimc Department of Chemistry and Cosmetics, College of Natural Sciences , Jeju National University , Jeju , South Korea.
Sang-Hee Byeonc Department of Chemistry and Cosmetics, College of Natural Sciences , Jeju National University , Jeju , South Korea.
Eun-Sook Yooa School of Medicine and Brain Korea 21 PLUS Program , Jeju National University , Jeju , South Korea.
Hee-Kyoung Kanga School of Medicine and Brain Korea 21 PLUS Program , Jeju National University , Jeju , South Korea.
Jin-Won Hyuna School of Medicine and Brain Korea 21 PLUS Program , Jeju National University , Jeju , South Korea.
Nam-Ho Leec Department of Chemistry and Cosmetics, College of Natural Sciences , Jeju National University , Jeju , South Korea.
Young-Sang Koha School of Medicine and Brain Korea 21 PLUS Program , Jeju National University , Jeju , South Korea.
Jeju National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextSeaweeds are rich in bioactive compounds in the form of vitamins, phycobilins, polyphenols, carotenoids, phycocyanins and polysaccharides; many of these are known to have advantageous applications in human health. 3-Hydroxy-4,7-megastigmadien-9-one (comp) was isolated from Ulva pertusa (U. pertusa) Kjellman (Ulvaceae), which is a familiar edible green seaweed.

objectiveThis study evaluates the anti-inflammatory activity of comp in CpG DNA-stimulated bone marrow-derived dendritic cells (BMDCs). MATERIALS AND

methodsFor evaluating the effect of comp on cytokines production, BMDCs were treated with doses of comp (0, 0.5, 1, 2, 5, 10, 25 and 50 μM) for 1 h before stimulation with CpG DNA (1 μM). Cytokine production was measured by ELISA. Western blotting was conducted for evaluating effect of comp (50 μM) on MAPKs and NF-κB pathways. Luciferase reporter gene assay was conducted for effect of comp (0, 5, 10 and 25 μM) on transcriptional activity of AP-1 and NF-κB.

resultsComp exhibited strong inhibition of interleukin (IL)-12 p40, IL-6 and TNF-α cytokine production with IC DISCUSSION AND

conclusionTaken together, these data suggest that comp has a significant anti-inflammatory property and warrants further studies concerning the potential of comp for medicinal use.

Indexed as

AnimalsAnti-Inflammatory AgentsCpG IslandsCytokinesDendritic CellsDose-Response Relationship, DrugEnzyme ActivationFemaleGenes, ReporterHEK293 CellsHumansInflammation MediatorsMice, Inbred C57BLMitogen-Activated Protein KinasesNF-kappa BNorisoprenoids3-hydroxyl-4,7-megastigmadien-9-oneAnti-Inflammatory AgentsCytokinesInflammation MediatorsMitogen-Activated Protein KinasesNF-kappa BNorisoprenoidsOligonucleotidesPlant ExtractsTlr9 protein, mouseToll-Like Receptor 9Transcription Factor AP-1BMDCsCpG-DNAmitogen-activated protein kinasePro-inflammatory cytokines

Identifiers

PMID27937044
PMCPMC6130523
OpenAlexW2565295060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.